Health Care & Life Sciences » Pharmaceuticals | SamChunDang Pharm Co. Ltd.

SamChunDang Pharm Co. Ltd. | Balance Sheet

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Cash & Short Term Investments
39,489
42,858
48,098
58,193
69,276
Total Accounts Receivable
30,883
33,944
32,687
38,618
39,065
Inventories
15,931
16,974
17,738
19,171
21,848
Other Current Assets
451
396
423
622
1,018
Total Current Assets
86,754
94,172
98,946
116,603
131,207
Net Property, Plant & Equipment
49,639
54,589
59,307
57,928
55,175
Total Investments and Advances
11,553
16,860
17,440
15,693
26,867
Intangible Assets
5,161
6,870
8,567
13,066
20,036
Other Assets
2,271
-
-
1,823
1,859
Total Assets
155,379
172,491
184,260
205,113
235,143
ST Debt & Current Portion LT Debt
15,824
5,134
4,631
6,979
2,336
Accounts Payable
3,302
7,320
4,770
3,828
4,435
Income Tax Payable
1,100
1,538
1,228
2,545
2,216
Other Current Liabilities
9,559
12,555
11,084
12,795
14,712
Total Current Liabilities
29,786
26,548
21,714
26,147
23,699
Long-Term Debt
1,374
-
-
-
3,000
Provision for Risks & Charges
3,250
4,986
7,353
7,442
7,734
Deferred Taxes
1,482
1,081
666
310
1,753
Other Liabilities
200
200
200
200
200
Total Liabilities
36,092
32,814
29,933
34,099
36,387
Common Equity (Total)
93,123
105,440
114,317
125,166
146,339
Total Shareholders' Equity
93,123
105,440
114,317
125,166
146,339
Total Equity
119,231
139,676
154,315
171,003
198,757
Liabilities & Shareholders' Equity
155,379
172,491
184,260
205,113
235,143
Accumulated Minority Interest
26,109
34,236
39,998
45,837
52,417
Non-Equity Reserves
55
-
12
12
-

About SamChunDang Pharm Co.

View Profile
Address
71 Jeyakgongdan 2-gil
Hwaseong-si GY 18622
Korea, Republic Of
Employees -
Website http://www.scd.co.kr
Updated 09/14/2018
Sam Chun Dang Pharm Co., Ltd. engages in the manufacture of pharmaceuticals. Its products include antibiotics, cures for circulatory and respiratory system, medicines for digestive system and ophtalmology, and anti-inflammatory. The company was founded on December 29, 1943 and is headquartered in Hwaseong-si, South Korea.